The size of the Hyaluronic Acid Products market in the Asia Pacific was around USD 1.93 Billion in 2021. It is expected to grow at a CAGR of 10.92% to reach USD 3.24 Billion by 2026.
Hyaluronic acid products have a wide range of applications in dermatology, orthopedic procedures, tissue engineering, and ophthalmology. Hyaluronic acid levels have been found to decrease with age, and consumers rely on hyaluronic acid-based dietary supplements or extra-oral injections to overcome hyaluronic acid deficiencies.
Hyaluronic acid injections are used in eye surgeries for cataract removal, corneal transplantation, repair of retinal detachment, and other eye injuries.
Hyaluronic acid injections have been widely used in osteoarthritis of the knee and effectively control pain and improve function. It is commonly prescribed as an intra-articular therapy for knee osteoarthritis. In terms of dermatology, hyaluronic acid products are used as dermal fillers to uplift sagging skin, erase fine lines, and build up facial muscle loss for the aging population and high awareness of beauty enhancements. Hyaluronic acid as fillers is generally biocompatible, which means that no allergy skin test is required before treatment.
Young and older age people are becoming more conscious of facial wrinkles and folds, and to improve the appearance of lips, this is one of the fastest driving factors driving the APAC hyaluronic acid products market during the forecast period. In addition, other factors driving market growth include the increasing geriatric population, increased demand for minimally invasive procedures, and increased availability of hyaluronic acid products. All these factors are estimated to drive the market in the APAC region.
However, there is a lack of knowledge about hyaluronic acid and poor healthcare infrastructure, especially in underdeveloped and rural areas. This is one of the main constraints faced by the APAC hyaluronic acid market. In addition, hyaluronic products can also show some minor side effects like itchiness, swelling, redness, and loss of sensation, among others. Due to this factor, there are strict rules for product approval, making the product expensive. Therefore, high prices and counterfeit products will negatively impact the market during the forecast period.
This research report on the APAC hyaluronic acid products market has been segmented and sub-segmented into the following categories:
By Product Type:
By Application:
By Country:
Geographically, the Asia-Pacific is predicted to experience tremendous growth during the forecast period. The Chinese hyaluronic acid fillers market is expected to grow at the highest CAGR of 8.5% during the forecast period. In China, the cosmetic surgery industry is progressing at a rapid pace, the demand for cosmetic treatments using hyaluronic acid is booming. The Chinese market has great potential due to its large size, aging population, and sedentary lifestyle. The market size of hyaluronic acid for medical beauty was 5.5 billion yuan in 2019 and is expected to more than double in the next five years. According to a recent Chinese report, from 2017 to 2020, the amount of hyaluronic acid sold annually in China increased from 135 tons to 315 tons, with an average annual growth of 26%.
Japan is likely to have the fastest-growing region because the country has one of the large aging population in the world. The regional economy is becoming an R&D-intensive economy, which is the primary driver of market growth in Japan. Factors such as increasing disposable income, influencing median income, and changing consumer habits drive this market.
Over the forecast period, the Indian hyaluronic acid products market is estimated to grow at a CAGR of 8.7%. The increase in disposable income, a high proportion of middle-aged people, increase in the prevalence of bone-related, the constant evolution of healthcare services, and growth in R&D activities would lead to the expansion of the Indian hyaluronic acid market during the forecast period.
KEY MARKET PLAYERS:
Companies playing a pivotal role in the Asia Pacific hyaluronic acid products market profiled in this report are Allergan, Sanofi, Ferring B.V., Zimmer Biomet, Fidia Farmceutici, Salix Pharmaceutical, Anika Therpeutics, Seikagaku Corporation, Hoffmann-LA Roche Ltd, Alcon, Inc., Smith & Nephew plc and F.Merz Asthetics, Inc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product Type
5.1.1 Introduction
5.1.2 Single Cycle Injection Products
5.1.3 Three Cycle Injectin Products
5.1.4 Five cycle injection Products
5.1.5 Y-o-Y Growth Analysis, By Product Type
5.1.6 Market Attractiveness Analysis, By Product Type
5.1.7 Market Share Analysis, By Product Type
5.2 Application
5.2.1 Introduction
5.2.2 Osteoarthritis
5.2.3 Ophthalmic
5.2.4 Dermal Filler
5.2.5 Vesicoureteral Reflux
5.2.5 Y-o-Y Growth Analysis, By Application
5.2.6 Market Attractiveness Analysis, By Application
5.2.7 Market Share Analysis, By Application
5.3 End User
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Home
5.3.4 Clinics
5.3.5 Y-o-Y Growth Analysis, By End User
5.3.6 Market Attractiveness Analysis, By End User
5.3.7 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product Type
6.1.3.3 By Application
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product Type
6.1.4.3 By Application
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product Type
6.1.5.3 By Application
6.1.5.4 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Zimmer Biomet
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 StemCells
8.3 Allergan
8.4 Sanofi
8.5 Ferring B.V
8.6 Fidia Farmceutici
8.7 Salix Pharmaceutical
8.8 Anika Therpeutics
8.9 Seikagaku Corporation
8.10 Hoffmann-LA Roche Ltd
8.11 Smith & nephew plc.
8.12 F.Merz Asthetics, inc
8.13 Alcon
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
